Epigenetic evidence revealed that the hypermethylation of 5ʹ α-promoter in colon carcinogenesis led to loss of DCLK1-L expression in cancerous cells, and alternative β-promoter activity in response to signaling pathways caused the expression of DCLK1-S in cancer cells [56]. This evidence concerns the gene DCLK1 and cancer.